Your Location：
Home >
Browse articles >
Yinxing Mihuan Oral Solution Protect HUVECs Against Hypoxia Reoxygenation Injury Through p38 MAPK Regulating eNOS/NO Signaling Pathway
Yinxing Mihuan Oral Solution Protect HUVECs Against Hypoxia Reoxygenation Injury Through p38 MAPK Regulating eNOS/NO Signaling Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 23, Pages: 79-84(2017)
DOI： 10.13422/j.cnki.syfjx.2017230079
Scan QR Code
Full Text(HTML)
Publication Info
Metrics
23
Views
36
Downloads
3
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Yinxing Mihuan Oral Solution on Neovascularization and Vascular Remodeling in Chemical Photothrombosis-induced Focal Cerebral Ischemia Mouse Model
Effect of Yinxing Mihuan Oral Solutionon P2RX7/NLRP3 Signaling Pathway in Depression Model Rats Induced by Isolation Combined with Chronic Unpredictable Mild Stress
Molecular Mechanisms of Yinxing Mihuan Oral Solution on Coronary Heart Disease and Anxiety Disorder Based on Network Pharmacology
Tongnao Decoction Promotes Angiogenesis and Alleviates Cerebral Ischemic Injury via PI3K/Akt/GSK-3β Signaling Pathway
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Related Author
LIU Jianxun
HE Shaoqing
WANG Yong
WANG Yimin
WANG Guangrui
SONG Wenting
YANG Bin
ZHANG Wei
Related Institution
Beijing Key Laboratory of Pharmacology of Chinese Materia Medica，Institute of Basic Medical Sciences of Xiyuan Hospital，China Academy of Chinese Medical Sciences
Xi'an Buchang Traditional Chinese Cardio-Cerebrovascular Disease Hospital
Beijing Key Laboratory of Pharmacology of Traditional Chinese Medicine， Institute of Basic Medical Sciences， Xiyuan Hospital， China Academy of Chinese Medical Sciences
Yunnan University of Chinese Medicine
Buchang Pharma
Chat
